lower estim reflect updat guidanc
manag commentari notabl offset tax reform benefit
maintain price target rate
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
million except per share datafisc year endingdecemb supplement disabl life servic fee invest medic medic supplement benefit disabl life benefit benefit benefit supplement loss disabl life loss supplement disabl life expens ex industri revenu invest oper expens order pharmaci supplement disabl life ex intang tax expens tax tax incom attribut ep ex intang ep averag share outstand dilut februari
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin februari et
analyst michael newshel matthew nicolai primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view research report
